InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,486.51
(
0.16%
)
US TECH 100
19,247.20
(
0.17%
)
Dow Jones
39,166.43
(
0.10%
)
Brent Oil
85.27
(
0.94%
)
Bitcoin
62,292.21
(
2.43%
)
Post# of 345995
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

tech0200

Send PM Follow Ignore
Followers 6
Posts 348
Boards Moderated 0
Alias Born 05/22/2006

tech0200

Re: Protector post# 205646

Sunday, 02/08/2015 10:16:53 AM

Sunday, February 08, 2015 10:16:53 AM

Post# of 345995

Possibly PPHM's 121 patients clinical trial wasn't even quoted for by many Big CRO's because to small.



If a big CRO had done the small phase II they probably would have done the much larger phase III. That's a really good way to get those phase III trials.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!